Inhibition of human smooth muscle cell proliferation by gamigeonsim-tang through the transcriptional regulation of cell cycle-controlling genes

American Journal of Chinese Medicine

Volumn 28, Issue 1, 2000, Pages 57-67

  Ko, Seong Gyu ^a   Lee, Kyung Sup ^a   Cho, Ki Ho ^a   Kim, Young Suk ^a   Bae, Hyung Sup ^a   Moon, Sang Kwan ^a  

^a Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CDKN1A PROTEIN, HUMAN; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; HERBACEOUS AGENT; HISTONE; MYC PROTEIN; PROTEIN C FOS; PROTEIN P53;

ARTICLE; CELL DIVISION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KOREA; SMOOTH MUSCLE; UPREGULATION;

CDC2 PROTEIN KINASE; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DOWN-REGULATION; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; GENES, CDC; HISTONES; HUMANS; KOREA; MUSCLE, SMOOTH; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 0033649429     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X00000088     Document Type: Article

References (25)

1. Borellini, F. and R.I. Glazer. Induction of Sp-p53 binding heterocomplexes during granulocyte macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell lineTF-l.y. Biol. Chem. 268: 7923-7928, 1993.
2. Casscells, W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 86: 723-731, 1992.
3. Chi, S.-G., R.W. devere White, F.J. Meyers, D. Siders, F. Lee and P.H. Gumerlock. p53 in prostate: frequent expressed transition mutations./ Natl. Cancer Inst. 86: 926-933, 1994.
4. Chomczynski, P. and N. Sacchi. Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
5. El-Deity, W.S., J.W. Harper, P.M. O'Connor, V.E. Velculescu, C.E. Canman, J. Jackman, J.A. Pietenpol, M. Brrrell, D.E. Hill, Y. Wang, K.G. Wiman, W.E. Mercer, M.B. Kastan, K.W. Kohn, S.J. Elledge, K.W. Kinzler and B.Vogelstein. Wafl/CIPl is induced in p53-mediated G, arrest and apoptosis. Cancer Res. 54: 1169-1174, 1994.
6. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler and B. Vogelstein Wafl, a potential mediator ofp53 tumor suppression. Cell 75: 817-825, 1993.
7. Ginsberg, D., F. Mechta, M. Yaniv and M. Oren. Wild-typep53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sei. USA 88: 9979-9983, 1991.
8. Grainger, D.J. Proliferation of human smooth muscle cells promoted by lipoprotein. Science 60: 1655-1658, 1993.
9. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi and S.J. Elledge The p21 cdk-interacting protein Cipl is a potent inhibitor of GI cyclin-dependent kinases. Cell 75: 805-816, 1993.
10. Kane, S.E., I. Pastan and M.M. Gottesman. Genetic basis of multidrug resistance of tumor cells. J. Bioenerq. Biomembr. 22: 593-618, 1990.
11. Kastan, M.B., O. Zhan, W.S. El-Deiry, F. Carrier, T. Jacks, W.V. Walsh, B.S. Plunkett and A.J., Jr. Fornace. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell 71: 587-597, 1992.
12. Kocher, O. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimai thickening. Lab. Invest. 65: 459-467, 1991.
13. Lane, O.P. p53, guardian of the genome. Nature 358: 15-16, 1992.
14. Levine, A.J. ThepJJ? tumor suppressor gene and product. Cancer Surveys 12: 59-79, 1992.
15. Mercer, W.E., M.T. Shields, D. Lin, E. Appella and S.J. Ullrich. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc. Natl. Acad. Sei. USA 88: 1958-1962, 1991.
16. Mercer, W.E., M.T. Shields, M. Amin, G.J. Sauve, E. Appella, J.W. Romano and S.J. Ullrich. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53 Proc. Natl. Acad. Sei. USA 87: 6166-6170, 1990.
17. Miyashita, T., M. Harigai, M. Hanada and J.C. Reed. Identification of a/?53-dependent negative response element in the bcl-2 gene. Cancer Res. 54: 3131-3135, 1994.
18. Nachman, R.L. Thrombosis and atherosclerosis: Molecular connections. Blood 79: 1897-1902, 1992.
19. Pober, J. and F.S. Cotran. Cytokines and smooth muscle cell biology. Physionl Rev. 70: 27-64, 1990.
20. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 62: 801-805, 1993.
21. Seto, E., A. Usheva, G.P. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A.J. Levine and T. Shenk. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Nail. Acad. Sei. USA 89: 12028-12032, 1992.
22. Simionescu, M. Smooth muscle cell response to normaland abnormal stimuli, odification, dysfunction, injury; adaptation, repair, death. In Simionescu, N., and Simionescu, M. (Ed). smooth muscle cell dysfunction. New York, Plenum Press, 1992, pp. 3-67.
23. Weintraub, H., S. Hauschka and S.J. Tapscott. The MCK enhancer contains ap53 responsive element. Proc. Natl. Acad. Sei. USA 88: 4570-4574, 1991.
24. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi and M. Oren. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
25. Zambetti, G., J. Bargonetti, K. Walker, C. Prives and A.J. Levine Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 6: 1143-1152,1992.